Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
140 Results Found
Amicus Brief: Academic Medical Centers Support AHA in 340B Case September 10, 2021
In 1990, Congress enacted the Medicaid Rebate Program, as part of the Omnibus Reconciliation Act of 1990 (Pub. L. No. 101-508).20. This law requires drug companies that choose to participate in Medicaid to give states, which administer Medicaid, discounts comparable to those given to other payers.
Amicus Brief: Lousiana Hospital Association, Rural Hospital Coalition, Inc., AHA, 340B Health
UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAFAYETTE DIVISION
AHA Comments on MedPAC's Site-neutral, Nurse Staffing Requirements October 2024 Meeting Discussion
October 27, 2023
Michael Chernew, Ph.D.
Chairman
Medicare Payment Advisory Commission
425 I Street, NW, Suite 701
Washington, DC 20001
Dear Dr. Chernew:
Amicus Brief: AHA 340B Health Arkansas Hospital Association in support of Arkansas’ 340B Drug Pricing Nondiscrimination Act
Amicus Brief: AHA 340B Health Arkansas Hospital Association in support of Arkansas’ 340B Drug Pricing Nondiscrimination Act against a challenge brought by PhRMA.
AHA, hospitals mandamus complaint to compel timely administrative review of Medicare claims denials
Plaintiffs the American Hospital Association (“AHA”), Baxter Regional Medical Center, Covenant Health, and Rutland Regional Medical Center (collectively, “Plaintiffs”) bring this mandamus complaint to compel the Secretary of Health and Human Services (“HHS”) to meet the statutory deadlines for administrative review of denials of claims for Medicare reimbursement.
Litigation
This page contains materials related to AHA’s current and active policy-related litigation.
Legal Brief Re: 340B Contract Pharmacy Case - Sanofi-Aventis U.S. v. HHS et al – January 30, 2023
Drugmakers that participate in the 340B drug pricing program do not have to provide discounted 340B drugs to an unlimited number of contract pharmacies, the U.S. Court of Appeals for the 3rd Circuit ruled in Sanofi-Aventis U.S. v. HHS et al.
Opinion Re: Plaintiffs Motion to Hold Unlawful and Remedy Defendants’ Past Underpayments of 340b Drugs
Memorandum Opinion: Granting in Part, Denying In Part Plaintiffs Motion to Hold Unlawful and Remedy Defendants’ Past Underpayments of 340b Drugs
Decision by U.S. District Judge Billy Roy Wilson Regarding the Legality of the 340B Drug Pricing Nondiscrimination Act
Pending are Plaintiff’s Motion for Summary Judgment on Preemption (Doc. No. 24), Defendant Leslie Rutledge’s Cross-Motion for Summary Judgment (Doc. No. 32), and Intervenors’ Cross-Motion for Summary Judgment on Preemption (Doc. No. 35). The parties have responded and replied.1 For the reasons set out below, Plaintiff’s motion is DENIED. Intervenors’ cross-motion is GRANTED. Defendant Leslie Rutledge’s cross-motion is DENIED as MOOT.
AHA Asks Court to Order HHS to Promptly Repay 340B Hospitals For Past Unlawful Cuts
AHA urges the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to promptly repay 340B hospitals for unlawful payment cuts in previous years, given the agency’s continued delay in implementing or even proposing a remedy on its own.